BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 21362027)

  • 21. Differential immunoreactivity of goat derived scrapie following in vitro misfolding versus mouse bioassay.
    Madsen-Bouterse SA; Zhuang D; O'Rourke KI; Schneider DA
    Biochem Biophys Res Commun; 2012 Jul; 423(4):770-4. PubMed ID: 22713450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A change in the conformation of prions accompanies the emergence of a new prion strain.
    Peretz D; Williamson RA; Legname G; Matsunaga Y; Vergara J; Burton DR; DeArmond SJ; Prusiner SB; Scott MR
    Neuron; 2002 Jun; 34(6):921-32. PubMed ID: 12086640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation.
    Murayama Y; Yoshioka M; Horii H; Takata M; Yokoyama T; Sudo T; Sato K; Shinagawa M; Mohri S
    Biochem Biophys Res Commun; 2006 Sep; 348(2):758-62. PubMed ID: 16890914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.
    Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T
    J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
    Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
    J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.
    Collinge J; Palmer MS; Sidle KC; Hill AF; Gowland I; Meads J; Asante E; Bradley R; Doey LJ; Lantos PL
    Nature; 1995 Dec 21-28; 378(6559):779-83. PubMed ID: 8524411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of PrPres in BSE-infected bovine PrP transgenic mice.
    Castilla J; Gutiérrez Adán A; Brun A; Pintado B; Ramírez MA; Parra B; Doyle D; Rogers M; Salguero FJ; Sánchez C; Sánchez-Vizcaíno JM; Torres JM
    Arch Virol; 2003 Apr; 148(4):677-91. PubMed ID: 12664293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of prion protein (PrP(Sc)) in the brains of hamsters inoculated serially with a mouse-passaged scrapie strain.
    Kimura K; Kubo M; Yokoyama T
    J Comp Pathol; 2000; 122(2-3):123-30. PubMed ID: 10684681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetone precipitation of the scrapie agent results in successful recovery of PrP(Sc) but decreased infectivity.
    Smith JD; Greenlee JJ; Foster GH; Nicholson EM
    J Agric Food Chem; 2012 May; 60(18):4758-62. PubMed ID: 22519670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.